Weight-loss drugs may aid in treating addiction and Alzheimer's, study finds
A new study suggests weight-loss medications, especially receptor agonists, could benefit brain function and potentially help treat addiction and Alzheimer's.
Key Takeaways
AIA recent study has found that weight-loss medications, particularly receptor agonists, may have a positive impact on cognitive and brain functions, with potential applications in treating addiction and Alzheimer's disease.
The study added that these drugs affect processes related to learning, memory, and other mental abilities. However, researchers noted that current results remain inconsistent, according to Asharq Bloomberg.
The study also emphasized the need for more rigorous clinical trials before these medications can be approved for treating neurological or behavioral disorders beyond their established uses. Scientists also aim to determine whether the drugs' effects on metabolic pathways could help maintain brain health as people age.